JANE STREET GROUP, LLC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1595888 NEW YORK, NY

Back to DNA Full portfolio

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

-$1,510,383 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

19 quarters on record

Common Shares in DNA Over Time

Shares Held

Position Value (USD)

Derivatives in DNA

reported options exposure · as of Jun 30, 2026

CallValue

$414,238

CallShares

41,800

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

All Filings in DNA

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$414,238	41,800	+98.9%	Call	Defined	2026-08-14
2025-12-31	$174,659	21,018	-80.0%	Call	Defined	2026-02-12
2025-12-31	$1,510,383	181,755	+113.8%	Shares	Defined	2026-02-12
2025-09-30	$220,158	15,100	-14.2%	Put	Defined	2025-11-14
2025-09-30	$1,532,503	105,110	+39.6%	Call	Defined	2025-11-14
2025-09-30	$1,239,575	85,019	+22.0%	Shares	Defined	2025-11-14
2025-06-30	$847,125	75,300	+108.6%	Call	Defined	2025-08-14
2025-03-31	$397,312	69,704	-98.6%	Shares	Defined	2025-05-19
2025-03-31	$205,770	36,100	-10.0%	Call	Defined	2025-05-19
2025-03-31	$100,320	17,600	-45.3%	Put	Defined	2025-05-19
2024-12-31	$316,204	32,200	+126.8%	Put	Defined	2025-02-14
2024-12-31	$394,017	40,124	-56.5%	Call	Defined	2025-02-14
2024-09-30	$115,730	14,200	-97.4%	Put	Defined	2024-11-15
2024-09-30	$751,348	92,190	-82.1%	Call	Defined	2024-11-15
2024-06-30	$1,663,759	4,981,317	+140.7%	Shares	Defined	2024-08-15
2024-03-31	$2,400,698	2,069,568	-43.3%	Shares	Defined	2024-05-16
2023-12-31 DNABW	—	20,177	-30.3%	Shares	Defined	2024-02-15
2023-12-31	$6,170,513	3,651,192	+124.1%	Shares	Defined	2024-02-15
2023-09-30 DNABW	—	28,938	0.0%	Shares	Defined	2023-11-15
2023-09-30	$2,948,328	1,628,911	-11.7%	Shares	Defined	2023-11-15
2023-06-30 DNABW	—	28,938	-2.5%	Shares	Defined	2023-08-14
2023-06-30	$3,430,526	1,844,369	+23.9%	Shares	Defined	2023-08-14
2023-03-31 DNABW	—	29,687	-6.1%	Shares	Defined	2023-05-16
2023-03-31	$1,979,594	1,488,417	+221.8%	Shares	Defined	2023-05-16
2022-12-31 DNABW	—	31,622	-7.6%	Shares	Defined	2023-02-15
2022-12-31	$781,758	462,579	-31.3%	Shares	Defined	2023-02-15
2022-09-30 DNABW	—	34,224	-11.2%	Shares	Defined	2022-11-15
2022-09-30	$2,100,564	673,258	+189.5%	Shares	Defined	2022-11-15
2022-06-30 DNABW	—	38,540	+18.6%	Shares	Defined	2022-08-16
2022-06-30	$553,396	232,520	+281.9%	Shares	Defined	2022-08-16
2022-03-31 DNABW	—	32,484	-9.5%	Shares	Defined	2022-05-17
2022-03-31	$2,213,276	549,200	+32.5%	Put	Defined	2022-05-17
2022-03-31	$2,075,853	515,100	-25.7%	Call	Defined	2022-05-17
2022-03-31	$245,378	60,888	-66.2%	Shares	Defined	2022-05-17
2021-12-31 DNABW	—	35,897	+19.4%	Shares	Defined	2022-02-15
2021-12-31	$5,759,661	693,100	+85.3%	Call	Defined	2022-02-15
2021-12-31	$3,445,326	414,600	+74.9%	Put	Defined	2022-02-15
2021-12-31	$1,496,322	180,063	+892.5%	Shares	Defined	2022-02-15
2021-09-30 DNABW	—	30,076	—	Shares	Defined	2021-11-16
2021-09-30	$210,277	18,143	—	Shares	Defined	2021-11-16
2021-09-30	$2,747,989	237,100	—	Put	Defined	2021-11-16
2021-09-30	$4,334,660	374,000	—	Call	Defined	2021-11-16
No filing history on record for this holder in this stock.